Analyst Price Targets — LTGO
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| September 1, 2026 10:16 am | Akash Tewari | Jefferies | $50.00 | $22.02 | StreetInsider | Jefferies Starts Latigo Biotherapeutics (LTGO) at Buy |
| September 1, 2026 10:06 am | — | Leerink Partners | $36.00 | $22.02 | TheFly | Latigo Biotherapeutics initiated with an Outperform at Leerink |
| September 1, 2026 9:24 am | Yatin Suneja | Guggenheim | $50.00 | $22.02 | TheFly | Latigo Biotherapeutics initiated with a Buy at Guggenheim |
| September 1, 2026 8:29 am | — | Goldman Sachs | $73.00 | $22.02 | TheFly | Latigo Biotherapeutics initiated with a Buy at Goldman Sachs |
Latest News for LTGO
Latigo Biotherapeutics (NASDAQ:LTGO) arrived on public markets with the kind of reception biotech bankers dream about.
Latigo Biotherapeutics, Inc. (NASDAQ: LTGO - Get Free Report) Director James Tananbaum bought 140,000 shares of the business's stock in a transaction that occurred on Monday, August 10th. The shares were acquired at an average price of $18.00 per share, for a total transaction of $2,520,000.00. Following the completion of the transaction, the director owned 2,008,024
Latigo Biotherapeutics, Inc. (NASDAQ: LTGO - Get Free Report) major shareholder Foresite Capital Management V, bought 140,000 shares of Latigo Biotherapeutics stock in a transaction on Monday, August 10th. The shares were purchased at an average price of $18.00 per share, for a total transaction of $2,520,000.00. Following the acquisition, the insider directly owned 2,008,024 shares
THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Latigo Biotherapeutics, Inc. (Latigo), a clinical-stage biopharmaceutical company developing innovative non-opioid pain medicines, today announced the publication of positive results from the abdominoplasty clinical trial evaluating LTG-001 for the treatment of moderate-to-severe acute postoperative pain as an original research article in the New England Journal of Medicine…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for LTGO.
U.S. House Trading
No House trades found for LTGO.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.